Mendota Financial Group »

Neurocrine Biosciences shares owned by Mendota Financial Group

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Mendota Financial Group from 13F filings

Historical chart of Mendota Financial Group investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Mendota Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Mendota Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $103k 750 137.92
2023-12-31 $149k 1.1k 131.76
2023-09-30 $127k 1.1k 112.50
2023-06-30 $106k 1.1k 94.30

More positions owned by Mendota Financial Group

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Dimensional Etf Trust Us Equity Etf (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Loews Corporation (L)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Meta Platforms Cl A (META)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
PAR Technology Corporation (PAR)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Capital Group International SHS (CGIE)

View all positions for Mendota Financial Group

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences